SCHEMBL3585330

SCHEMBL3585330

C=CCc1c(O)ccnc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 1/20 0.40
XDH P47989 1/20 0.38
MEN1 O00255 4/20 0.37
MAPT P10636 4/20 0.37
KMT2A Q03164 4/20 0.37
GABRA1 P14867 3/20 0.37
GABRB2 P47870 3/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
GAA P10253 2/20 0.37
ALDH2 P05091 1/20 0.37
AKR1B1 P15121 1/20 0.37
HPGD P15428 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
IMPDH2 P12268 1/20 0.33
CASP1 P29466 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL323547 0.75 XDH (0.54) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL2059464 0.74 CDC7 (0.35) SRD5A1XDHMEN1MAPTKMT2A
Hydrogen Sulfide SCHEMBL6721312 0.73 XDH (0.52) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL28287534 0.72 SRC (0.33) MEN1MAPTKMT2AALDH1A1KDM4E
SCHEMBL69556 0.72 GABRA1 (0.48) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL6398012 0.70 SRD5A1 (0.49) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL6013229 0.70 GABRA1 (0.52) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL1413853 0.70 SRD5A1 (0.49) SRD5A1XDHMEN1MAPTKMT2A
SCHEMBL5583739 0.68 ERN1 (0.51) SRD5A1MEN1MAPTKMT2AALDH1A1
SCHEMBL4564372 0.68 XDH (0.33) XDHMEN1MAPTKMT2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745454-B2 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 ELAN PHARMACEUTICALS, INC. (US) 2010-06-29 US disclosed
US-20050085459-A1 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 KONRADI ANDREI W (US) 2005-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050085459-A1 Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 VCAM1, ICAM1, CD4 SRD5A1 2701/4885XDH 2748/4885MEN1 1381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.